Dr. Turaga reflects on the dedication and team behind the new consensus guidelines for peritoneal mesothelioma: “Now we have a way—we’re connected, advancing care, and doing what’s right for our patients. This consensus platform will help move the field forward."
Surgeons and researchers from Yale Cancer Center presented new findings at the Society of Surgical Oncology’s 2026 Annual Meeting in Phoenix held from March 5 to 7. The conference brings together surgical oncologists from all over the world to discuss practice-changing breakthroughs in cancer care.
Yale Cancer Center experts shared the latest advances in research areas covering rare cancers, genetic testing, cellular immunotherapy, tracheal stenting, robotic-assisted surgery, and more.
Dr. Su presents a robotic right hepatectomy highlighting advanced planning and vascular control to ensure a safe surgery with minimal bleeding.
Key steps include:
Early control of major hepatic veins
Real-time ultrasound to map vessels
Imaging to confirm liver perfusion
Intermittent blood flow control
Dr. Brown presents an analysis of MSK-MET tumors finding chromosome 12p gain may be a key biomarker in pancreatic ductal adenocarcinoma, potentially identifying patients most likely to benefit from KRAS-targeted therapies.
Dr. Turaga reflects on the dedication and team behind the new consensus guidelines for peritoneal mesothelioma: “Now we have a way—we’re connected, advancing care, and doing what’s right for our patients. This consensus platform will help move the field forward.
Dr. Gupta shows how mass-based response testing (MRT) can guide treatment decisions in peritoneal metastases by identifying patients likely to resist therapy. Tumors flagged as resistant by MRT were strongly linked to progression.
Dr. Su presents a robotic right hepatectomy highlighting advanced planning and vascular control to ensure a safe surgery with minimal bleeding.
Key steps include:
Early control of major hepatic veins
Real-time ultrasound to map vessels
Imaging to confirm liver perfusion
Intermittent blood flow control
Dr. Brown presents an analysis of MSK-MET tumors finding chromosome 12p gain may be a key biomarker in pancreatic ductal adenocarcinoma, potentially identifying patients most likely to benefit from KRAS-targeted therapies.
Dr. Turaga reflects on the dedication and team behind the new consensus guidelines for peritoneal mesothelioma: “Now we have a way—we’re connected, advancing care, and doing what’s right for our patients. This consensus platform will help move the field forward.
Dr. Gupta shows how mass-based response testing (MRT) can guide treatment decisions in peritoneal metastases by identifying patients likely to resist therapy. Tumors flagged as resistant by MRT were strongly linked to progression.
Dr. Su presents a robotic right hepatectomy highlighting advanced planning and vascular control to ensure a safe surgery with minimal bleeding.
Key steps include:
Early control of major hepatic veins
Real-time ultrasound to map vessels
Imaging to confirm liver perfusion
Intermittent blood flow control
Dr. Brown presents an analysis of MSK-MET tumors finding chromosome 12p gain may be a key biomarker in pancreatic ductal adenocarcinoma, potentially identifying patients most likely to benefit from KRAS-targeted therapies.
Dr. Turaga reflects on the dedication and team behind the new consensus guidelines for peritoneal mesothelioma: “Now we have a way—we’re connected, advancing care, and doing what’s right for our patients. This consensus platform will help move the field forward.
Dr. Gupta shows how mass-based response testing (MRT) can guide treatment decisions in peritoneal metastases by identifying patients likely to resist therapy. Tumors flagged as resistant by MRT were strongly linked to progression.
New research presented by Dr. Nicole Aguirre supports routine germline testing in appendiceal peritoneal surface malignancies.
> 1/3 harbored germline variants
50% of alterations involved DNA repair pathways
A wonderful evening was hosted by Dr. Kiran Turaga with colleagues, alumni, and friends from Yale Surgery across the country.
A wonderful evening was hosted by Dr. Kiran Turaga with colleagues, alumni, and friends from Yale Surgery across the country.
New research presented by Dr. Nicole Aguirre supports routine germline testing in appendiceal peritoneal surface malignancies.
> 1/3 harbored germline variants
50% of alterations involved DNA repair pathways
A wonderful evening was hosted by Dr. Kiran Turaga with colleagues, alumni, and friends from Yale Surgery across the country.
A wonderful evening was hosted by Dr. Kiran Turaga with colleagues, alumni, and friends from Yale Surgery across the country.
New research presented by Dr. Nicole Aguirre supports routine germline testing in appendiceal peritoneal surface malignancies.
> 1/3 harbored germline variants
50% of alterations involved DNA repair pathways
A wonderful evening was hosted by Dr. Kiran Turaga with colleagues, alumni, and friends from Yale Surgery across the country.
A wonderful evening was hosted by Dr. Kiran Turaga with colleagues, alumni, and friends from Yale Surgery across the country.
Copy Link